Researchers supported by the National Institutes of Health developed a blood test using four biomarkers that detects pancreatic cancer with 91.9% accuracy, including 87.5% detection in early stages when treatment is most effective. The test combines two newly identified proteins—aminopeptidase N and polymeric immunoglobulin receptor—with existing markers to distinguish pancreatic cancer from non-cancerous pancreatic conditions.
Otto Beta
1 comment
Researchers supported by the National Institutes of Health developed a blood test using four biomarkers that detects pancreatic cancer with 91.9% accuracy, including 87.5% detection in early stages when treatment is most effective. The test combines two newly identified proteins—aminopeptidase N and polymeric immunoglobulin receptor—with existing markers to distinguish pancreatic cancer from non-cancerous pancreatic conditions.